Your browser doesn't support javascript.
loading
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension.
Burmester, Gerd R; Strand, Vibeke; Rubbert-Roth, Andrea; Amital, Howard; Raskina, Tatiana; Gómez-Centeno, Antonio; Pena-Rossi, Claudia; Gervitz, Leon; Thangavelu, Karthinathan; St John, Gregory; Boklage, Susan; Genovese, Mark C.
Afiliação
  • Burmester GR; Department of Rheumatology and Clinical Immunology, Charité - Medical University Berlin, Free University, and Humboldt University Berlin, Berlin, Germany.
  • Strand V; Department of Immunology and Rheumatology, Stanford University, Palo Alto, California, USA.
  • Rubbert-Roth A; Klinik für Rheumatologie, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Amital H; Department of Medicine 'B' and Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
  • Raskina T; Faculty of Therapeutics, Kemerovo State Medical Academy of Roszdrav, Kemerovo, Russian Federation.
  • Gómez-Centeno A; Servicio de Reumatología, Parc Taulí Hospital Universitari, Barcelona, Spain.
  • Pena-Rossi C; Immunology and Inflammation, Sanofi, Bridgewater, New Jersey, USA.
  • Gervitz L; Medical Operations and Effectiveness, Sanofi Genzyme, Cambridge, Massachusetts, USA.
  • Thangavelu K; Biostatistics, Sanofi Genzyme, Cambridge, Massachusetts, USA.
  • St John G; Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Boklage S; Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Genovese MC; Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California, USA.
RMD Open ; 5(2): e001017, 2019.
Article em En | MEDLINE | ID: mdl-31673415
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Substituição de Medicamentos / Anticorpos Monoclonais Humanizados / Adalimumab Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: RMD Open Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Substituição de Medicamentos / Anticorpos Monoclonais Humanizados / Adalimumab Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: RMD Open Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido